|

Therapeutic Adherence of Multiple Sclerosis Patients

RECRUITINGSponsored by Lille Catholic University
Actively Recruiting
SponsorLille Catholic University
Started2022-01-18
Est. completion2025-01-18
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04837352

Summary

The goal of this study is to assess the role of sociocognitive and interpersonal factors in the therapeutic adherence of multiple sclerosis patients. This study will provide a better understanding of the socio-psychological issues associated with different types of non-adherence to treatment, and identify the risk factors and vulnerability of each patient.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Multiple sclerosis defined according to McDonald criteria;
* Already undergone or beginning substantive treatment (self-managed, excluding treatment administered in hospital)
* Aged ≥ 18 years;
* Given the informed consent form.

Exclusion Criteria:

* Severe cognitive impairment (score below the 5th percentile);
* Any associated neurological pathology or serious or chronic somatic disease (cancer);
* Being under a legal protection measure.

Conditions1

Multiple Sclerosis

Browse More Trials

Multiple Sclerosis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.